Laura L. Truskowski

发表

Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study.

J. Torner, N. Kassell, E. Haley, 1995, Critical care medicine.

A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.

J. Torner, N. Kassell, N. Kassell, 1994, Journal of neurosurgery.

A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

W. Alves, H. Yonas, G. Ferguson, 1995, Neurosurgery.

Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse?

J. Torner, N. Kassell, J. Jane, 1996, Journal of neurosurgery.

A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

W. Alves, N. Kassell, N. Knuckey, 1995, Neurosurgery.

Gender-related differences in aneurysmal subarachnoid hemorrhage.

W. Alves, J. Torner, N. Kassell, 1996, Journal of neurosurgery.

Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.

A Pasqualin, N W Dorsch, W. Alves, 1999, Journal of neurosurgery.

Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators.

W. Koroshetz, J. Saver, R. Wityk, 1999, Stroke.